arrow
N

Neal R. Swerdlow

university of washington seattle
H指数:92
被引数:3.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Machine learning enables efficient neurocognitive profiling in patients with schizophrenia

机器学习赋能精神分裂症患者高效神经认知特征分析

2026-01-010
PRE
Do cognitive and neurophysiological effects of acute memantine “challenge” predict its clinical benefits in Alzheimer’s Disease?

认知和神经生理学效应能否预测急性美金刚“挑战”在阿尔茨海默病中的临床获益?

2025-09-220
OAAI
Pharmacologic Augmentation of Computerized Auditory Training in Chronic Psychosis: Preliminary Findings From a Single-Site, Double-Blind Study

计算机化听觉训练在慢性精神病中的药理学增强:一项单中心、双盲研究的初步发现

2025-04-140
PRE
Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across Species

美金刚对物种对40Hz刺激的听觉稳态和谐波反应的影响

2024-03-013
PRE
Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders

失配负性可预测跨精神疾病的异质人群中基于听觉的初始针对性认知训练表现

2023-09-012
OAAI
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden

精神分裂症内表型生物标志物对抗胆碱能药物负担的敏感性

2023-07-0110
PRE
COMPARING THE IMPACT OF SCHIZOPHRENIA POLYGENIC SCORES, IQ POLYGENIC SCORES, AND ANTI-CHOLINERGIC MEDICATION BURDEN ON NEUROCOGNI-TIVE FUNCTIONING IN THE CONSORTIUM ON THE GE-NOMICS OF SCHIZOPHRENIA (COGS2) STUDY

比较精神分裂症多基因评分,智商多基因评分和抗胆碱能药物负担对精神分裂症遗传经济学联盟 (cos2) 研究中神经认知功能的影响

2022-10-010
PRE
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia

精神分裂症抗胆碱能药物负担相关的认知障碍

2021-09-0195
OA